| Structure |
Chemical Name |
CAS |
MF |
 |
15-KETO PROSTAGLANDIN F1ALPHA |
21562-58-3 |
C20H34O5 |
 |
DINOPROSTONE ETHANOLAMIDE |
194935-38-1 |
C22H37NO5 |
 |
N-(2-HYDROXYETHYL)-11-OXO-9ALPHA,15S-DIHYDROXY-PROSTA-5Z,13E-DIEN-1-AMIDE |
398138-28-8 |
C22H37NO5 |
 |
2,3-DINOR-8-ISO PGF1ALPHA |
|
C18H32O5 |
 |
1a,1b-dihomoprostaglandin E2 |
26198-80-1 |
C22H36O5 |
 |
1A,1B-DIHOMO PROSTAGLANDIN F2ALPHA |
57944-39-5 |
C22H38O5 |
 |
(13E,15S)-15-Hydroxy-9-oxoprosta-11,13-dien-1-oic acid |
35687-86-6 |
C20H32O4 |
 |
11-DEOXY PROSTAGLANDIN F2BETA |
37786-07-5 |
C20H34O4 |
 |
13,14-DIHYDRO-19(R)-HYDROXY PROSTAGLANDIN E1 |
|
C20H36O6 |
 |
19(R)-HYDROXY PROSTAGLANDIN A2 |
52087-58-8 |
C20H30O5 |
 |
19(R)-HYDROXY PROSTAGLANDIN B2 |
|
C20H30O5 |
 |
13,14-DIHYDRO-15-KETO PROSTAGLANDIN F1ALPHA |
29044-75-5 |
C20H36O5 |
 |
2,3-DINOR PROSTAGLANDIN E1 |
7046-40-4 |
C18H30O5 |
 |
PGK1 |
|
|
 |
20-ETHYL PROSTAGLANDIN E2 |
37492-24-3 |
C22H36O5 |
 |
PXGPLTODNUVGFL-SGSFECARSA-N |
1240398-18-8 |
C20H34O5 |
 |
11-OXO-PROSTA-5Z,9,12E,14Z-TETRAEN-1-OIC-3,3,4,4-D4 ACID |
|
C20H26D4O4 |
 |
13,14-dihydro-15-keto Prostaglandin D2-d4 |
|
C20H28D4O5 |
 |
Prostaglandin E2 serinol amide |
951209-67-9 |
C23H39NO6 |
 |
9ALPHA, 11ALPHA, 15S-TRIHYDROXY-PROSTA-5Z, 13E-DIEN-1-OIC ACID, 1,9-LACTONE |
55314-48-2 |
C20H32O4 |
 |
N-ACETYL LEUKOTRIENE E4 |
80115-95-3 |
C25H39NO6S |
 |
19-hydroxyprostaglandin E2 |
55123-68-7 |
C20H32O6 |
 |
PGD-M |
133161-96-3 |
C16H24O7 |
|
|
13,14-dihydro-15-keto Prostaglandin D1 |
|
|
 |
Prostaglandin E2-d9 |
1356347-42-6 |
C20H23D9O5 |
 |
LEUKOTRIENE B4 DIMETHYL AMIDE |
83024-92-4 |
C22H37NO3 |
 |
5,6-dihydroxyprostaglandin E1 |
90817-53-1 |
C20H34O7 |
 |
N-(2-HYDROXYETHYL)-9ALPHA, 11ALPHA, 15S-TRIHYDROXY-PROSTA-5Z, 13E-DIEN-1-AMIDE-3,3,4,4-D4 |
|
C22H35D4NO5 |
 |
13,14-dihydro-15-keto Prostaglandin F2α-d4 |
42932-59-2 |
C20H34O5 |
 |
ALPROSTADIL ETHANOLAMIDE |
210976-81-1 |
C22H39NO5 |
 |
15-ketoprostaglandin I2 |
100311-07-7 |
C20H30O5 |
 |
LEUKOTRIENE F4 |
83851-42-7 |
C28H44N2O8S |
 |
13,14-dihydro-15-keto-tetranor Prostaglandin D2 |
1204116-69-7 |
C16H26O5 |
 |
20-hydroxyprostaglandin E1 |
57930-99-1 |
C20H34O6 |
 |
dihomo-prostaglandin I(2) |
99286-22-3 |
C22H36O5 |
 |
LEUKOTRIENE B4 ETHANOLAMIDE |
|
C22H37NO4 |
 |
PGE2-1,15-lactone |
62410-93-9 |
C20H30O4 |
 |
tetranor-PGDM-d6 |
1314905-92-4 |
C16H24O7 |
 |
11BETA-PGF2ALPHA-EA |
714966-38-8 |
C22H39NO5 |
 |
8-EPI PGF1ALPHA |
26771-96-0 |
C20H36O5 |
 |
LEUKOTRIENE C4 |
72025-60-6 |
C30H47N3O9S |
 |
9-hydroxy-11,15-dioxo-2,3,18,19-tetranorprost-5-ene-1,20-dioic acid |
70803-92-8 |
C16H22O7 |
 |
prostaglandin F-main urinary metabolite |
34069-62-0 |
C18H30O6 |
 |
13,14-dihydro-15-keto-tetranor Prostaglandin E2 |
20675-85-8 |
C16H26O5 |
 |
9-OXO-15S-HYDROXY-PROSTA-5Z,8(12),13E-TRIEN-1-OIC-3,3,4,4-D4 ACID |
|
C20H26D4O4 |
 |
LEUKOTRIENE B4 |
71160-24-2 |
C20H32O4 |
 |
UNOPROSTONE |
120373-36-6 |
C22H38O5 |
 |
9ALPHA, 15S-DIHYDROXY-11-OXO-PROST-13E-EN-1-OIC-3,3,4,4-D4 ACID |
|
C20H30D4O5 |
 |
11BETA-13, 14-DIHYDRO-15-KETO PROSTAGLANDIN F2ALPHA |
107615-77-0 |
C20H34O5 |
 |
Prostaglandin D2-d9 |
|
C20H23D9O5 |
 |
tetranor-PGJM |
1352751-83-7 |
C16H22O6 |
|
|
13,14-Dihydro-15-keto-PGE2-d4 |
|
|
 |
tetranor-PGAM |
52510-53-9 |
C16H22O6 |
 |
LEUKOTRIENE E4 |
75715-89-8 |
C23H37NO5S |
 |
7,9,11,13,17-Eicosapentaenoic acid, 5,6,15-trihydroxy-, (5S-(5R*,6R*,7 E,9E,11Z,13Z,15R*,17Z))- |
95851-20-0 |
C20H30O5 |
 |
16-carboxytetranordihyroleukotriene E4 |
122069-63-0 |
C19H29NO7S |
 |
14,15-LEUKOTRIENE C4 |
75290-60-7 |
C30H47N3O9S |
 |
9ALPHA, 11, 15S-TRIHYDROXY-THROMBA-5Z, 13E, 17Z-TRIEN-1-OIC ACID |
71953-80-5 |
C20H32O6 |
 |
LIPOXIN A4 |
89663-86-5 |
C20H32O5 |
 |
LIPOXIN B4 |
98049-69-5 |
C20H32O5 |
 |
12(S)-HHT |
54397-84-1 |
C17H28O3 |
 |
15(S)-HETRE |
13222-49-6 |
C20H34O3 |
 |
(5S,12S)-DIHYDROXY-(6E,8E,10E,14Z)-EICOSATETRAENOIC ACID |
71548-19-1 |
C20H32O4 |
 |
5,14,15-Trihydroxy-6,8,10,12,17-eicosapentaenoic acid |
95851-21-1 |
C20H30O5 |
 |
lipoxin C4 |
85951-62-8 |
C30H47N3O10S |
 |
9ALPHA,11,15S-TRIHYDROXY-THROMBOX-13E-EN-1-OIC ACID |
64626-32-0 |
C20H36O6 |
 |
(+/-)8,9-DIHETRE |
|
C20H34O4 |
 |
9ALPHA,11,15S-TRIHYDROXY-THROMBA-5Z,13E-DIEN-1-OIC-3,3,4,4-D4 ACID |
1346112-79-5 |
C20H30D4O6 |
 |
(+/-)11,12-DIHETRE |
|
C20H34O4 |
 |
2,3-DINOR THROMBOXANE B2 |
63250-09-9 |
C18H30O6 |
 |
12-EPI LEUKOTRIENE B4 |
83709-73-3 |
C20H32O4 |
 |
20-TRIFLUORO LEUKOTRIENE B4 |
115178-97-7 |
C20H29F3O4 |
 |
IXAQOQZEOGMIQS-YUMLLTTFSA-N |
1622429-53-1 |
C20H32O5 |
 |
2,3-DINOR THROMBOXANE B1 |
|
C18H32O6 |
|
|
LEUKOTRIENE D5 |
|
|
![(5S,6R,7E,9E,11Z)-6-[(2R)-2-amino-3-hydroxy-3-oxopropyl]sulfanyl-5-hydroxyicosa-7,9,11-trienoic acid](/CAS/GIF/79494-05-6.gif) |
(5S,6R,7E,9E,11Z)-6-[(2R)-2-amino-3-hydroxy-3-oxopropyl]sulfanyl-5-hydroxyicosa-7,9,11-trienoic acid |
79494-05-6 |
C23H39NO5S |
![7-[3-(3-hydroxyoct-1-enyl)-4,6-dioxabicyclo[3.1.1]hept-2-yl]hept-5-enoic acid](/CAS/GIF/57576-52-0.gif) |
7-[3-(3-hydroxyoct-1-enyl)-4,6-dioxabicyclo[3.1.1]hept-2-yl]hept-5-enoic acid |
57576-52-0 |
C20H32O5 |
|
|
20-carboxyleukotriene E4 |
|
|
 |
thromboxane A3 |
60114-68-3 |
C20H30O5 |
 |
14,15-leukotriene A4 |
81918-96-9 |
C20H30O3 |
 |
18-carboxy-19,20-dinor-N-acetylleukotriene E4 |
114115-51-4 |
C23H33NO8S |
 |
15-hydroxy-5,6-oxido-7,9,11,13-eicosatetraenoic acid |
94235-42-4 |
C20H30O4 |
 |
20-carboxy-N-acetylleukotriene E4 |
112066-58-7 |
C25H37NO8S |
 |
(+/-)5,6-DIHETRE |
|
C20H34O4 |
 |
14,15-LEUKOTRIENE D4 |
75290-64-1 |
C25H40N2O6S |
 |
11-DEHYDRO THROMBOXANE B2 |
67910-12-7 |
C20H32O6 |
 |
lipoxin E4 |
85963-48-0 |
C23H37NO6S |
 |
11-DEHYDRO THROMBOXANE B3 |
129228-55-3 |
C20H30O6 |
 |
(2R,3S)-3-heptyl-2-octyl-oxane |
66719-58-2 |
C20H40O |
 |
20-aldehyde leukotriene B4 |
115609-68-2 |
C20H30O5 |
 |
11-dehydro-13,14-dihydro-15-keto-thromboxane B2 |
79250-58-1 |
C20H32O6 |
 |
(5S,6R,15R)-5,6,15-TRIHYDROXY-7,9,13-TRANS-11-CIS-EICOSATETRAENOIC ACID |
171030-11-8 |
C20H32O5 |
 |
(5S,6Z,8E,10E,14Z)-5-hydroxy-12-oxoicosa-6,8,10,14-tetraenoic acid |
136696-10-1 |
C20H30O4 |
![4-[(2S,3S)-3-[(1E,3E,5Z,8Z)-tetradeca-1,3,5,8-tetraenyl]oxiran-2-yl]butanoic acid](/CAS/GIF/72059-45-1.gif) |
4-[(2S,3S)-3-[(1E,3E,5Z,8Z)-tetradeca-1,3,5,8-tetraenyl]oxiran-2-yl]butanoic acid |
72059-45-1 |
C20H30O3 |
 |
11-TRANS LEUKOTRIENE C4 |
74841-69-3 |
C30H47N3O9S |
 |
5(S)-HETRE |
195061-94-0 |
C20H34O3 |
 |
lipoxin D4 |
85994-54-3 |
C25H40N2O7S |
 |
14,15-DEHYDRO LEUKOTRIENE B4 |
114616-11-4 |
C20H30O4 |
 |
(5S,12R)-5,12,20-TRIHYDROXY-(6Z,8E,10E,14Z)-EICOSATETRAENOIC ACID |
79516-82-8 |
C20H32O5 |
 |
11-DEHYDRO THROMBOXANE B2-D4 |
1240398-15-5 |
C20H30D4O5 |